GREENWOOD CAPITAL ASSOCIATES LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1161822 GREENWOOD, SC

Position in CRSP

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$333,839

+$68,829 QoQ

Shares Held

6,121

-9.1% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#256

of 519 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GREENWOOD CAPITAL ASSOCIATES LLC holds $17,673,711 across 9 Biotechnology names. CRSP ranks #8 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	13,873	$8,650,370
2	VRTX	Vertex Pharmaceuticals Inc / Ma	12,024	$5,972,681
3	HALO	Halozyme Therapeutics, Inc.	7,752	$606,749
4	KRYS	Krystal Biotech, Inc.	1,495	$555,646
5	EXEL	Exelixis, Inc.	8,152	$443,550
6	MDGL	Madrigal Pharmaceuticals, Inc.	773	$415,062
7	INCY	Incyte Corp	3,319	$376,241
8	CRSP	CRISPR Therapeutics AG This page	6,121	$333,839

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$333,839	6,121	-9.1%	Shares	Sole	2026-07-28
2024-12-31	$265,010	6,733	-3.3%	Shares	Sole	2025-01-27
2024-09-30	$327,262	6,966	-2.3%	Shares	Sole	2024-10-30
2024-06-30	$384,983	7,128	+6.5%	Shares	Sole	2024-08-08
2024-03-31	$456,263	6,694	-1.6%	Shares	Sole	2024-05-01
2023-12-31	$425,742	6,801	+23.8%	Shares	Sole	2024-03-05
2023-09-30	$249,418	5,495	+0.6%	Shares	Sole	2023-10-18
2023-06-30	$306,748	5,464	-3.0%	Shares	Sole	2023-08-07
2023-03-31	$254,690	5,631	-91.3%	Shares	Sole	2023-05-12
2022-12-31	$2,642,453	65,005	+8.2%	Shares	Sole	2023-01-26
2022-09-30	$3,924,594	60,055	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.